🔖
Cite This Article
WIWANITKIT, S., WIWANITKIT, V. (2012). Tissue inhibitor of metalloproteinases-1, hyaluronan and chronic hepatitis. Turkish Journal of Gastroenterology, Cilt: 23 - Sayı: 6, 823–823. https://ajindex.com/articles/411114
Journals / Turkish Journal of Gastroenterology / 2012 / Cilt: 23 - Sayı: 6
Tissue inhibitor of metalloproteinases-1, hyaluronan and chronic hepatitis
- Pages
- 823–823
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (4)
- Seven G, Karatayli SC, Köse SK, et al. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D. Turk J Gastroenterol 2011; 22: 305-14
- Zaman A, Rosen HR, Ingram K, et al. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Am J Med 2007; 120: 280.e9-14
- Young-Min S, Cawston T, Marshall N, et al. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. Arthritis Rheum 2007; 56: 3236-47
- Mroczko B, Groblewska M, Lukaszewicz-Zajac M, et al. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients. Clin Chem Lab Med 2009; 47: 1133-9.